You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-Polycythemia Vera Myelofibrosis (PPV-MF)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

Completed
  • Myelofibrosis
  • +3 more
  • Ann Arbor, Michigan
  • +4 more
Mar 28, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide

Completed
  • Idiopathic Myelofibrosis
  • +2 more
  • Paris, France
  • +9 more
Jun 22, 2021

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

Completed
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +21 more
Aug 25, 2021

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
Jan 18, 2022

Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

Recruiting
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2023

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Worcester, Massachusetts
  • +16 more
Oct 31, 2022

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • Canton, Ohio
      Site 01
    Aug 18, 2022

    Myelofibrosis Trial in Worldwide (PXS-5505)

    Recruiting
    • Myelofibrosis
    • Birmingham, Alabama
    • +19 more
    Nov 28, 2022

    Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Farmington Hills, Michigan
    • +1 more
    Jun 5, 2021

    Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

    Recruiting
    • Myelofibrosis; Anemia
    • +5 more
    • Jacksonville, Florida
    • +6 more
    Jan 3, 2023

    A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

    Active, not recruiting
    • Primary Myelofibrosis
    • +2 more
    • Jakavi
    • Aachen, Germany
      Novartis Investigative Site
    Sep 6, 2021

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Primary Myelofibrosis Trial (Pacritinib)

    Withdrawn
    • Primary Myelofibrosis
    • Pacritinib
    • (no location specified)
    May 3, 2021